Notably, the clinical trials MAGMA and JCOG1703 further demonstrated that some treatment regimens for newly diagnosed GBMs (ndGBMs).
Company Provides a Temporary Leadership Transition Update and Highlights Continued Momentum Across Its Defense and Industrial Programs ORLANDO, FL / ACCESS Newswire / June 29, 2026 / Laser Photonics ...
Company Provides a Temporary Leadership Transition Update and Highlights Continued Momentum Across Its Defense and Industrial Programs ORLANDO, FL / ACCESS Newswire / June 29, 2026 / Laser Photonics C ...
Shenzhen University researchers, with industry partners, developed a black phosphorus-based all-fiber photonic AI platform ...
New models continue to hit the market at a rapid rate of knots – and with another handful to be released over the next 12 ...
As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...
Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader ...
Click here to view the custom infographic of the Quantum BioPharma editorial.
The convergence of indigenous knowledge systems and emerging technologies continues to redefine the boundaries of ...
Sjögren’s disease (SjD) is a chronic, multisystem autoimmune disorder characterised by lymphocytic infiltration of exocrine ...
Morning Overview on MSN
Scientists say the power to regrow lost body parts may be switched off, not gone, in mammals
Researchers at Texas A&M University have demonstrated that mice can regrow bone, joint structures, and ligaments after digit ...
Morning Overview on MSN
Cancer drugs already sitting on pharmacy shelves reversed Alzheimer’s damage in mice
Two FDA-approved cancer drugs, letrozole and irinotecan, reversed Alzheimer’s-related molecular damage and improved disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results